Do I need radiation after Hodgkin lymphoma chemotherapy? From PET results to a treatment plan

A favorable PET result after chemotherapy does not always mean that radiation has become unnecessary. In some early-stage Hodgkin lymphoma pathways, local radiation was part of the intended treatment from the beginning. Other pathways allow selected patients to omit it after a defined response. The decision depends on the complete treatment strategy, not on the words PET-negative in isolation.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Consolidative radiation aims to reduce recurrence at selected sites after systemic treatment. Radiation can also be considered as part of treatment for localized residual or recurrent disease, or to relieve a troublesome symptom. These purposes do not necessarily use the same field, dose, or schedule. A proposal described simply as a few extra sessions leaves too much unexplained.[S2]
Simulation records the treatment position and the anatomy needed to design the plan. It may involve a support device or skin markings. Contouring, dose calculation, and quality checks follow. A simulation appointment is therefore not necessarily the first radiation appointment, and its date should not be used on its own to calculate when an international patient can fly home.[S16]
Before booking travel, establish that the hospital has reviewed adequate records and can coordinate consultation, simulation, planning, and delivery in the medically appropriate period. A RMB quotation should identify whether simulation, planning, fractions, image verification, and on-treatment reviews are included. If proton and photon treatment are both proposed, ask to compare the clinical reasoning and plans rather than package names alone.[S12]

Quick answer

Full guide

Bring the hematology history and imaging into the radiation consultation. The original distribution of disease, drugs actually administered, and timing of response scans can all matter. A hospital asked to plan treatment using only the latest scan may lack information about the sites present before chemotherapy. Original images are particularly valuable when radiation is being arranged in China after drug treatment elsewhere.[S40]

Identify the purpose of the proposed radiation

Consolidative radiation aims to reduce recurrence at selected sites after systemic treatment. Radiation can also be considered as part of treatment for localized residual or recurrent disease, or to relieve a troublesome symptom. These purposes do not necessarily use the same field, dose, or schedule. A proposal described simply as a few extra sessions leaves too much unexplained.[S2]

Ask the radiation oncologist to show which area is being treated and why a local intervention adds value at this stage. If omission is recommended, ask for the reasoning and the follow-up plan. When two centers disagree, first establish whether they are using the same stage, chemotherapy record, and scan interpretation. A difference in the information available can look like a disagreement about the evidence.

Why a negative PET scan gives different answers in different trials

In HD16, omission of radiation after a defined short course of ABVD in early favorable Hodgkin lymphoma resulted in more relapses despite a negative PET result. The excess included recurrences in areas that would otherwise have been irradiated. This finding illustrates why the response scan cannot replace evidence about the full treatment pathway.[S25]

HD17 addressed a different question. It studied early unfavorable disease treated with two cycles of escalated BEACOPP followed by two cycles of ABVD, then used PET to guide radiation. Its findings support omission under the conditions studied. They should not be combined with HD16 into a rule that all early-stage patients can avoid radiation. The chemotherapy intensity and eligibility conditions are part of each result.[S24]

A remaining PET signal needs interpretation

An area of uptake may require review of scan timing, inflammation, infection, and the pattern of change. The team can consider the Deauville assessment alongside the original images and clinical findings. Depending on the uncertainty and its consequences, the next step may involve expert review, an appropriately timed repeat assessment, biopsy, or further treatment. A bright spot is not something a patient can independently classify as surviving lymphoma.[S28]

If an additional treatment is being proposed for one site, ask how confident the team is about the diagnosis and whether tissue confirmation would change the decision. Treating inflammation as refractory lymphoma can expose someone to unnecessary therapy. Conversely, genuine progression may call for a broader salvage strategy rather than simply adding a few radiation visits. The radiation and lymphoma teams need to agree on what problem they are solving.

How involved-site treatment is planned

Involved-site radiation therapy, or ISRT, uses information about the areas originally affected and the anatomy after systemic treatment. It is more limited than historical extended-field approaches. Planning still has to account for the quality of baseline imaging, movement of organs, and reproducibility of the treatment position. Asking to shrink the field to a tiny visible dot may remove a margin needed for reliable treatment.[S40]

For an international transfer, request the original diagnostic CT and PET/CT in DICOM format. A photograph of a report is useful for an initial inquiry but is not a substitute for the image data. If radiation was given previously, obtain the earlier plan, prescribed dose, fractionation, and dose distribution when available. Reirradiation requires assessment of overlapping exposure; the fact that earlier treatment occurred years ago does not make that information irrelevant.

Discuss the organs close to the target

Mediastinal disease can lie near the heart, lungs, and breast tissue. The plan must therefore consider exposure to these structures. Age, individual anatomy, previous doxorubicin or bleomycin, and existing cardiopulmonary disease can affect the discussion. Ask which organs deserve particular attention in your case and which planning choices reduce their exposure.[S1][S41]

This is more informative than asking whether a machine is the newest model. Intensity modulation, image guidance, breath-hold techniques, and proton therapy may improve a plan under suitable conditions. Their value should be demonstrated through the person's dose distribution and clinical needs. A more expensive technology does not automatically provide better lymphoma control, and no device name means that every late effect has been eliminated.[S41]

Breath-hold is a reproducible technique, not a test of endurance

For selected chest treatments, deep inspiration breath-hold can change the relative positions of structures and help spare normal tissue. The benefit depends on the plan and the patient's ability to repeat the position. Radiation therapists explain the breathing instructions and how the treatment system checks them. Do not introduce a different breathing pattern during delivery without their direction.[S40]

Tell the planning team about coughing, anxiety, or breathlessness that makes the technique difficult. They may adjust the approach or assess another method. Holding a breath once for a long time is less useful than reproducing the required position reliably over the course. Patients should not feel that difficulty with breath-hold is a personal failure or a reason to conceal discomfort from the staff.

Simulation comes before treatment delivery

Simulation records the treatment position and the anatomy needed to design the plan. It may involve a support device or skin markings. Contouring, dose calculation, and quality checks follow. A simulation appointment is therefore not necessarily the first radiation appointment, and its date should not be used on its own to calculate when an international patient can fly home.[S16]

Mention claustrophobia, pain, shoulder limitation, or difficulty lying flat before the position is finalized. Comfort affects whether the same posture can be maintained repeatedly. Arrange language support in advance: once positioned, turning to use a phone may be difficult. Ask how to signal that something is wrong and make sure the instruction is understood before the team leaves the room.

Read the total dose together with the fraction schedule

Radiation dose is usually expressed in gray, abbreviated Gy, and divided into fractions. Two courses with the same number of visits may deliver different doses. A dose used for one objective or body region may not suit another. Obtain the prescribed total, dose per fraction, intended number of fractions, and target area, then ask how these fit the current clinical purpose.[S40]

An interruption also needs a documented response. If illness or a service disruption changes an appointment, contact the department about the revised schedule. Do not independently compress the remaining visits or assume that an omitted session is inconsequential. The team needs to consider why treatment stopped and for how long. Travel and accommodation arrangements are easier to manage when they allow some adjustment to the medical calendar.

What happens in the treatment room

External radiation usually cannot be felt as the beam enters the body, although remaining still can make an existing painful position uncomfortable. The therapists continue to observe and communicate after leaving the room. Use the agreed signal if you suddenly feel unwell. Staff can assess whether positioning or another problem needs attention; enduring an intolerable position does not improve treatment accuracy.[S16]

External-beam radiation does not leave the body radioactive, so it does not require avoiding family members for that reason. Nuclear medicine tests performed around the same time may come with their own temporary instructions. Follow the instructions for the procedure actually received. Confusing a PET tracer with external-beam treatment can create unnecessary separation at home or lead someone to disregard advice intended for the scan.

Acute effects depend on the treated region

Neck or mediastinal treatment can cause swallowing discomfort when relevant tissues are in the field. Skin reactions tend to occur in the irradiated area. Abdominal irradiation has a different pattern of possible digestive symptoms. Another patient's easy experience with a different field cannot establish what should happen in yours. Report symptoms according to the body's response, not according to a comparison in a patient group.[S17][S42]

Ask the radiation nurses about washing, moisturizing, and medicines for the treated skin. Avoid applying irritating products without checking them. Reduced fluid intake, inability to swallow tablets, or new breathing difficulty needs a prompt discussion. Supportive care can be changed during the course. Waiting until the last fraction to mention a problem may allow dehydration or another manageable complication to become harder to treat.[S43]

Plan daily life around changing energy

Travel to the department, disrupted sleep, inadequate nutrition, and other symptoms can add to fatigue. Put essential activities at times when energy is usually better and arrange help with transport or household tasks when needed. Persistent exhaustion also deserves assessment for contributing causes; it should not automatically be dismissed as anxiety or a lack of effort.[S39]

A person finishing chemotherapy may expect radiation visits to fit easily around full-time work. That may be possible, but the practical limit can change during the course. Discuss a flexible return with an employer rather than promising overtime immediately after every appointment. Sudden worsening accompanied by fever, chest discomfort, or dizziness should be reported rather than treated as an inevitable part of recovery.

Keep an exposure record for long-term care

Some consequences of treatment arise much later. Neck exposure may influence thyroid monitoring; chest exposure can affect planning for cardiovascular or breast follow-up. The appropriate approach depends on age, dose, fields, and other treatment. Historical risk estimates from large radiation fields are not a personal forecast for a modern plan, while smaller fields do not mean that long-term follow-up is unnecessary.[S1][S13]

Request a completion summary with the site, dates, total dose, fractions, and relevant organ-dose information. A statement that someone “had radiotherapy” leaves future clinicians unable to assess exposure properly. Keep the summary with the drug history and provide it to the doctor responsible for ongoing screening. The patient does not need to independently arrange every possible scan each year; surveillance should reflect the actual treatment received.

Confirm the practical arrangements in China

Before booking travel, establish that the hospital has reviewed adequate records and can coordinate consultation, simulation, planning, and delivery in the medically appropriate period. A RMB quotation should identify whether simulation, planning, fractions, image verification, and on-treatment reviews are included. If proton and photon treatment are both proposed, ask to compare the clinical reasoning and plans rather than package names alone.[S12]

The final fraction does not automatically mark the end of all care. Arrange management of acute reactions and the next lymphoma assessment. Before departure, the team should consider swallowing, hydration, stamina, and any other active treatment. A fixed flight date cannot determine medical readiness. Identify a clinician at home who can review ongoing symptoms and receive the radiation summary.[S22]

The decision to use or omit radiation should leave a clear record: the disease findings and treatment pathway supporting it, the local risk being addressed, the expected burden, and the follow-up needed afterward. That record makes a second opinion easier to interpret and gives the patient something more useful than a general assurance that radiation is either always necessary or always avoidable.